Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone

被引:13
|
作者
Moes, Arthur D. [1 ]
Severs, David [1 ]
Verdonk, Koen [2 ]
van der Lubbe, Nils [1 ]
Zietse, Robert [1 ]
Danser, A. H. J. [2 ]
Hoorn, Ewout J. [1 ]
机构
[1] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[2] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Div Pharmacol & Vasc Med, Rotterdam, Netherlands
来源
FRONTIERS IN PHYSIOLOGY | 2018年 / 9卷
关键词
angiotensin II; endothelin-1; salt-sensitive hypertension; sodium transporters; wire myographs; II TYPE-2 RECEPTOR; SODIUM-CHLORIDE COTRANSPORTER; IMMUNE CELL INFILTRATION; NA-CL COTRANSPORTER; ANGIOTENSIN-II; BLOOD-PRESSURE; SENSITIVE HYPERTENSION; MEDIATED VASODILATION; ACTIVATION; VASOCONSTRICTION;
D O I
10.3389/fphys.2018.00578
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Inflammation is increasingly recognized as a driver of hypertension. Both genetic and pharmacological inhibition of B and T cells attenuates most forms of experimental hypertension. Accordingly, the immunosuppressive drug mycophenolate mofetil (MMF) reduces blood pressure in the deoxycorticosterone acetate (DOCA-) salt model. However, the mechanisms by which MMF prevent hypertension in the DOCA-salt model remain unclear. Recent studies indicate that immunosuppression can inhibit sodium transporter activity in the kidney, but its effect on vascular tone is not well characterized. Therefore, the aim of the present study was to analyze the vascular and renal tubular effects of MMF in the DOCA-salt model in rats (4 weeks without uninephrectomy). Co-treatment with MMF attenuated the rise in blood pressure from day 11 onward resulting in a significantly lower telemetric mean arterial pressure after 4 weeks of treatment (108 +/- 7 vs. 130 +/- 9 mmHg, P < 0.001 by two-way analysis of variance). MMF significantly reduced the number of CD3(+) cells in kidney cortex and inner medulla, but not in outer medulla. In addition, MMF significantly reduced urinary interferon-gamma excretion. Vascular tone was studied ex vivo using wire myographs. An angiotensin II type 2 {AT(2)) receptor antagonist blocked the effects of angiotensin II (Ang II) only in the vehicle group. Conversely, L-NAME significantly increased the Mg II response only in the MMF group. An endothelin A receptor blocker prevented vasoconstriction by endothelin-1 in the MMF but not in the vehicle group. MMF did not reduce the abundances of the kidney sodium transporters NHE3, NKCC2, NCC, or ENaC. Together, our ex vivo results suggest that DOCA-salt induces AT(2) receptor-mediated vasoconstriction. MMF prevents this response and increases nitric oxide availability. These data provide insight in the antihypertensive mechanism of MMF and the role of inflammation in dysregulating vascular tone.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension
    Grobe, Justin L.
    Mecca, Adam P.
    Mao, Haoyu
    Katovich, Michael J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (06): : H2417 - H2423
  • [42] Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments
    Cerrudo, Carolina S.
    Cavallero, Susana
    Rodriguez Fermepin, Martin
    Gonzalez, German E.
    Donato, Martin
    Kouyoumdzian, Nicolas M.
    Gelpi, Ricardo J.
    Hertig, Cecilia M.
    Choi, Marcelo R.
    Fernandez, Belisario E.
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [43] Polyphenols restore endothelial function in DOCA-salt hypertension:: Role of endothelin-1 and NADPH oxidase
    Jimenez, Rosario
    Lopez-Sepulveda, Rocio
    Kadmiri, Maria
    Romero, Miguel
    Vera, Rocio
    Sanchez, Manuel
    Vargas, Felix
    O'Valle, Francisco
    Zarzuelo, Antonio
    Duenas, Montserrat
    Santos-Buelga, Celestino
    Duarte, Juan
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (03) : 462 - 473
  • [44] Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats
    Baranowska-Kuczko, Marta
    Kozlowska, Hanna
    Kloza, Monika
    Karpinska, Olga
    Toczek, Marek
    Harasim, Ewa
    Kasacka, Irena
    Malinowska, Barbara
    LIFE SCIENCES, 2016, 151 : 288 - 299
  • [45] COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats
    Wang, Fei
    Sun, Ying
    Luo, Renfei
    Lu, Xiaohan
    Yang, Baoxue
    Yang, Tianxin
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (04) : F647 - F653
  • [46] Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats
    Lan, Chao-zong
    Ding, Ling
    Su, Yi-lin
    Guo, Kun
    Wang, Li
    Kan, Hong-wei
    Ou, Yu-rong
    Gao, Shan
    FOOD & FUNCTION, 2015, 6 (07) : 2179 - 2186
  • [47] Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats
    Xu, H
    Fink, GD
    Galligan, JJ
    HYPERTENSION, 2004, 43 (02) : 329 - 334
  • [48] Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension
    Wang, Youping
    Wang, Donna H.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 297 (06) : F1550 - F1559
  • [49] Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat
    Banek, Christopher T.
    Gauthier, Madeline M.
    Baumann, Daniel C.
    Van Heiden, Dusty
    Asirvatham-Jeyaraj, Ninitha
    Panoskaltsis-Mortari, Angela
    Fink, Gregory D.
    Osborn, John W.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2018, 314 (06) : R883 - R891
  • [50] mPGES-1 Protects Against DOCA-Salt Hypertension via Inhibition of Oxidative Stress or Stimulation of NO/cGMP
    Jia, Zhanjun
    Aoyagi, Toshinori
    Yang, Tianxin
    HYPERTENSION, 2010, 55 (02) : 539 - 546